Peroxisome Proliferator Activated Receptor-<i>α</i> Agonist Slows the Progression of Hypertension, Attenuates Plasma
Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin
II Infused Mice

<table>Renal CYP4A and CYP2J protein expression levels relative to <i>β</i>-actin in WT and PPAR<i>α</i> KO control, Ang II-infused and Ang II-infused + fenofibrate-treated mice. *indicates a significant increase versus control WT mice (<svg height="10.8125" id="M41" style="vertical-align:-0.10033pt" version="1.1" viewbox="0 0 35.099998 10.8125" width="35.099998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,10.8125)">
<g transform="translate(72,-63.35)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">4</tspan>
</text>
</g>
</g>
</svg> per group).</table>

PPAR Research

fig5

Figure 5

Figure 5: Peroxisome Proliferator Activated Receptor-<i>α</i> Agonist Slows the Progression of Hypertension, Attenuates Plasma
Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin
II Infused Mice 

Figure 5 | Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma
Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin
II Infused Mice 

PPAR Research

Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice

Figure 5